Desmoid tumor: Analysis of prognostic factors and outcomes in a surgical series

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4028-4035

  Mullen, John T ^a   DeLaney, Thomas F ^a   Kobayashi, Wendy K ^a   Szymonifka, Jackie ^a   Yeap, Beow Y ^a   Chen, Yen Lin ^a   Rosenberg, Andrew E ^a   Harmon, David C ^a   Choy, Edwin ^a   Yoon, Sam S ^a   Raskin, Kevin A ^a   Nielsen, G Petur ^a   Hornicek, Francis J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; IMATINIB; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TAMOXIFEN;

ADULT; CANCER RECURRENCE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DESMOID TUMOR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RARE DISEASE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; COMBINED MODALITY THERAPY; FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876468490     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2638-2     Document Type: Review

References (27)

1. Alman BA, Pajerski ME, Diaz-Cano S, et al. Aggressive fibro-matosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol. 1997;6:98-101. (Pubitemid 27155030)
2. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibroma-tosis is a clonal process. Hum Pathol. 1996;27:939-43.
3. Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34:462-8. (Pubitemid 351381296)
4. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29:3553-8.
5. Acker JC, Bossen EH, Halperin EC. The management of desmoid tumors. Int J Radiat Oncol Biol Phys. 1993;26:851-8. (Pubitemid 23229842)
6. Karakousis CP, Mayordomo J, Zografos GC, Driscoll DL. Des-moid tumors of the trunk and extremity. Cancer. 1993;72: 1637-41.
7. Lopez R, Kemalyan N, Moseley HS, et al. Problems in diagnosis and management of desmoid tumors. Am J Surg. 1990;159: 450-3. (Pubitemid 20160997)
8. McKinnon JG, Neifeld JP, Kay S, et al. Management of desmoid tumors. Surg Gynecol Obstet. 1989;169:104-6. (Pubitemid 19200139)
9. Plukker JT, Van Oort I, Vermey A, et al. Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg. 1995;82:510-4.
10. Rock MG, Pritchard DJ, Reiman HM, et al. Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984;66:1369-74. (Pubitemid 15177122)
11. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998;40:637-45. (Pubitemid 28104234)
12. Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor. Not a benign disease. Arch Surg. 1989;124:191-6. (Pubitemid 19059743)
13. Pritchard DJ, Nascimento AG, Petersen IA. Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1996; 78:848-54. (Pubitemid 26241987)
14. Sorensen A, Keller J, Nielsen OS, Jensen OM. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand. 2002;73:213-9. (Pubitemid 34557064)
15. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999; 17:158-67. (Pubitemid 29022389)
16. Huang K, Fu H, Shi YQ, et al. Prognostic factors for extraabdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol. 2009;100:563-9.
17. Merchant NB, Lewis JJ, Woodruff JM, et al. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999;86:2045-52.
18. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-7. (Pubitemid 46606421)
19. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25:1785-91. (Pubitemid 46797962)
20. Goy BW, Lee SP, Eilber F, et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 1997;39:659-65. (Pubitemid 27441433)
21. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi III A.T. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517-23. (Pubitemid 30183134)
22. Ballo MT, Zagars GK, Pollack A. Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 1998;42:1007-14. (Pubitemid 29004142)
23. Gluck I, Griffith KA, Biermann JS, et al. Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 2011;80:787-92.
24. Micke O, Seegenschmiedt MH. Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national patterns of care study. Int J Radiat Oncol Biol Phys. 2005;61:882-91. (Pubitemid 40247987)
25. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993;72:3244-7. (Pubitemid 23356767)
26. de Camargo VP, Keohan ML, D'Adamo DR, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 2010;116:2258-65.
27. Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibroma-tosis: a frontline conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16:2587-93.